FUSE-AI GmbH
Exhibitors
Information
FUSE-AI offers Prostate.Carcinoma.ai, a containerized AI-based solution package, that redefines prostate MRI analysis
Enhance your PACS or diagnostic DICOM viewer with new features and seamlessly integrate the containerized analysis module into your trusted diagnostic software. Prostate.Carcinoma.ai facilitates MRI analysis by providing reliable and robust segmentation of the prostate, its zones and suspicious lesions. Prostate.Carcinoma.ai has recently been certified according to (EU) MDR IIa.
Benefits:
- The automation of tedious process steps associated with manual segmentation frees up human resources to compensate the lack of qualified medical professionals
- More accurate and consistent segmentation of the prostate on MRI allows not only a more accurate calculation of prostate volume and PSA density but also a more accurate follow-up TRUS-guided biopsy with a better choice of treatment options
- Reducing the workload for radiologists by automating manual process steps can lead to an improvement in job satisfaction
Nature of Business
Manufacturer
Country
Germany
Interested to connect with
Healthcare Agent/Dealer/DistributorInvestorManufacturer
Imaging
Diagnostic and Therapy/MRI Machines
IT Systems, Solutions & Digital Health
Digital Health and Artificial Intelligence/eHealth, Telemedicine, Telematics, TelemetryData Analytics, Management and Analysis/Big DataData Analytics, Management and Analysis/Real time AnalyticsData Warehousing/Image Archiving, PACSSoftware and Mobile Content/Diagnostic Software
